Steroids are the treatment of choice for patients with IgG4-related diseases.
In patients with IgG4-related pachymeningitis, response to MTX can be suboptimal.
Rituximab has been shown to be effective in patients with IgG4-related pachymeningitis.
Early RTX treatment should be considered in patients with IgG4-related pachymeningitis.